Study: Pattanittum 2021, Cochrane Database of Systematic Reviews
Roselle for hypertension in adults
Citation
Pattanittum P, Ngamjarus C, Buttramee F, Somboonporn C (2021). Cochrane Database of Systematic Reviews. PubMed id 34837382.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Hibiscus (sorrel, zobo, bissap) and blood pressure Tier A thin
B Adults with high blood pressure; strict Cochrane criteria (n=52)
Cochrane review of randomised trials of roselle against placebo or no treatment, searched to August 2021.
Only one trial met the criteria (60 people with type 2 diabetes, 8 weeks, capsules). Effect on systolic pressure was 1.65 mmHg (95% CI -7.89 to 11.19), very low certainty. The review concludes evidence is insufficient to say whether roselle lowers blood pressure.
As recorded in this card: Pattanittum P, Ngamjarus C, Buttramee F, Somboonporn C (2021), Cochrane Database of Systematic Reviews, [review]
Note: Counter-evidence. Cochrane's inclusion rules were narrower than the 2025 umbrella review, which is why they disagree.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.